Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Finotello

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Genome Medicine|July 31, 2019
Correction to: Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq dataFrancesca Finotello, Clemens Mayer, Christina Plattner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2019
Guadecitabine Plus Ipilimumab in Unresectable Melanoma: The NIBIT-M4 Clinical TrialAnna Maria Di Giacomo, Alessia Covre, Francesca Finotello, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2014
Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolismJoão Fadista, Petter Vikman, Emilia Ottosson Laakso, et al.
Iscience|December 4, 2023
Functional and spatial proteomics profiling reveals intra- and intercellular signaling crosstalk in colorectal cancerChristina Plattner, Giorgia Lamberti, Peter Blattmann, et al.
Nature Cancer|July 23, 2025
Author Correction: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR<sup>+</sup>HER2<sup>-</sup> breast cancer via CX3CR1<sup>+</sup> macrophagesGiulia Petroni, Claudia Galassi, Kenneth H Gouin, et al.
Nature Cancer|July 7, 2025
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR<sup>+</sup>HER2<sup>-</sup> breast cancer via CX3CR1<sup>+</sup> macrophagesGiulia Petroni, Claudia Galassi, Kenneth H Gouin, et al.
Journal of Translational Medicine|February 21, 2024
A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancerMike Mason, Óscar Lapuente-Santana, Anni S Halkola, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Genome Medicine|July 31, 2019
Correction to: Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq dataFrancesca Finotello, Clemens Mayer, Christina Plattner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2019
Guadecitabine Plus Ipilimumab in Unresectable Melanoma: The NIBIT-M4 Clinical TrialAnna Maria Di Giacomo, Alessia Covre, Francesca Finotello, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2014
Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolismJoão Fadista, Petter Vikman, Emilia Ottosson Laakso, et al.
Iscience|December 4, 2023
Functional and spatial proteomics profiling reveals intra- and intercellular signaling crosstalk in colorectal cancerChristina Plattner, Giorgia Lamberti, Peter Blattmann, et al.
Nature Cancer|July 23, 2025
Author Correction: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR<sup>+</sup>HER2<sup>-</sup> breast cancer via CX3CR1<sup>+</sup> macrophagesGiulia Petroni, Claudia Galassi, Kenneth H Gouin, et al.
Nature Cancer|July 7, 2025
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR<sup>+</sup>HER2<sup>-</sup> breast cancer via CX3CR1<sup>+</sup> macrophagesGiulia Petroni, Claudia Galassi, Kenneth H Gouin, et al.
Journal of Translational Medicine|February 21, 2024
A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancerMike Mason, Óscar Lapuente-Santana, Anni S Halkola, et al.
Pageof 7